Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
Mar Biotechnol (NY). 2010 Oct;12(5):569-78. doi: 10.1007/s10126-009-9244-8. Epub 2009 Nov 27.
Genetically modified (GM) fish with desirable features such as rapid growth, disease resistance, and cold tolerance, among other traits, have been established in aquaculture. However, commercially available GM fish are restricted because of global concerns over the incomplete assessments of food safety and ecological impact. The ecological impact concerns include gene flow and escape of the GM fish, which may cause extinction of wild natural fish stocks. Infertility control is a core technology for overcoming this obstacle. Although polyploidy technology, GnRH-specific antisense RNA, and RNAi against GnRH gene expression have been used to cause infertility in fish, these approaches are not 100% reliable and are not heritable. In the present study, zebrafish was used as a model to establish an inducible platform of infertility control in GM fish. Nitroreductase, which converts metronidazole substrate into cytotoxin, was fused with EGFP and expressed specifically by oocytes in the Tg(ZP:NTR-EGFP) by a zona pellucida promoter. Through consecutive immersion of metronidazole from 28 to 42 days posthatching, oocyte-specific EGFP expression was eliminated, and atrophy of the gonads was detected by anatomical analysis. These findings reveal that oocyte-specific nitroreductase-mediated catalysis of metronidazole blocks oogenesis and leads to an undeveloped oocyte. Furthermore, oocyte cell death via apoptosis was detected by a TUNEL assay. We found that the gonadal dysgenesis induced by metronidazole resulted in activation of the ovarian killer gene bok, which is a proapoptotic gene member of the Bcl-2 family and led to infertility. These results show that oocyte-specific nitroreductase-mediated catalysis of metronidazole can cause reliable infertility in zebrafish and could potentially be used as a model for other aquaculture fish species.
具有快速生长、抗病和耐寒等特性的转基因(GM)鱼类已在水产养殖中建立。然而,由于对食品安全和生态影响评估不完整的全球担忧,可商业获得的 GM 鱼类受到限制。生态影响的担忧包括 GM 鱼类的基因流动和逃逸,这可能导致野生自然鱼类种群的灭绝。不育控制是克服这一障碍的核心技术。尽管多倍体技术、促性腺激素释放激素(GnRH)特异性反义 RNA 和 GnRH 基因表达的 RNAi 已被用于使鱼类不育,但这些方法并不完全可靠,也不具有遗传性。在本研究中,使用斑马鱼作为模型,在 GM 鱼类中建立了不育控制的诱导平台。硝基还原酶将甲硝唑底物转化为细胞毒素,与 EGFP 融合,并通过透明带启动子特异性地在 Tg(ZP:NTR-EGFP)中的卵母细胞中表达。通过从孵化后第 28 天到第 42 天连续浸泡甲硝唑,卵母细胞特异性的 EGFP 表达被消除,并且通过解剖分析检测到性腺萎缩。这些发现表明,卵母细胞特异性的硝基还原酶介导的甲硝唑催化阻止了卵子发生,并导致未发育的卵母细胞。此外,通过 TUNEL 测定检测到卵母细胞细胞凋亡。我们发现,甲硝唑引起的性腺发育不良导致卵巢杀伤基因 bok 的激活,bok 是 Bcl-2 家族的促凋亡基因成员,导致不育。这些结果表明,卵母细胞特异性的硝基还原酶介导的甲硝唑催化可以在斑马鱼中引起可靠的不育,并可能被用作其他水产养殖鱼类物种的模型。